1.	High-dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2010-0113, NCT01266603
2.	Clinical Study to Evaluate the Safety and Efficacy of recMAGE-A3 + AS-15 in Patients From Which the Bladder is Removed Due to Muscle Invasive Bladder Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: EAU RF 2010-01, NTR2846, 2010-024355-85, NCT01435356
3.	Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MCC-16545, NCT01437605
4.	MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: LGS 2009-005, 10-051, 10-216, NCT01380145